Furthermore, knocking out apoA-I resulted in an accelerated atherosclerosis development in several animal models (i.e. the human apoB-transgenic female mice; the LDL receptor-deficient; the LDL receptor/apoE-deficient mice) [15,16]. The gene discussed is APOA1; the disease is atherosclerosis.